World & BusinessKobayashi Pharmaceutical reportedly weighs potential buyout offer of more than ¥500 billion
The Japanese health products company was at the center of a supplement contamination scandal involving suspected deaths, Bloomberg reports.
TLDR
Kobayashi Pharmaceutical is said to be considering a potential buyout offer of more than ¥500 billion ($3.2 billion) from private equity investors, Bloomberg reports. The company was at the center of a supplement contamination scandal involving suspected deaths.
Kobayashi Pharmaceutical reportedly weighs potential buyout offer of more than ¥500 billion
The Japanese health products company was at the center of a supplement contamination scandal involving suspected deaths, Bloomberg reports.